Gregory J. Dore
Expertise in
7
conditions

Gregory J. Dore

St Vincent's Hospital
Darlinghurst, NSW, AU 
Expertise in
7
conditions
St Vincent's Hospital
Darlinghurst, NSW, AU 

Overview

Gregory Dore practices practicing medicine in Darlinghurst, Australia.

Mr. Dore is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Hepatitis C, Hepatitis, Hepatitis B, HIV/AIDS, and Hormone Replacement Therapy (HRT).

He is actively involved in clinical research, co-authoring 424 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

St Vincent's Hospital
Darlinghurst, NSW, Australia
Other Locations
UNSW Sydney, High St, Kensington, NSW 2052, Australia
High St, Kensington, NSW 2052, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

An Open Label, Multicentre, International Pilot Study of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir With or Without Ribavirin or Glecaprevir/Pibrentasvir for People With Recently Acquired Hepatitis C Virus Infection With or Without HIV Co-infection.
An Open Label, Multicentre, International Pilot Study of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir With or Without Ribavirin or Glecaprevir/Pibrentasvir for People With Recently Acquired Hepatitis C Virus Infection With or Without HIV Co-infection.
Enrollment Status: Completed
Publish Date: August 22, 2022
Intervention Type: Drug
Study Drugs: Paritaprevir+Ritonavir+Ombitasvir, Dasabuvir, Ribavirin, Glecaprevir+Pibrentasvir
Study Phase: Phase 3
A Phase II, Open-label, Single Arm, Multicentre, International Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
A Phase II, Open-label, Single Arm, Multicentre, International Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use
Enrollment Status: Completed
Publish Date: February 27, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

424 Total Publications

Hepatitis C: innovations in therapeutic interventions and elimination strategies.
Hepatitis C: innovations in therapeutic interventions and elimination strategies.
Journal: Expert review of gastroenterology & hepatology
Published: August 14, 2026

Frequently Asked Questions about Gregory J. Dore

Is Gregory J. Dore a top-rated expert for Hepatitis C?

MediFind is an objective health platform that identifies experts based on real-world data. Gregory J. Dore is classified as an Elite expert for Hepatitis C, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gregory J. Dore participate in research or clinical trials?

Yes. Gregory J. Dore has published 424 articles and abstracts on conditions like Hepatitis C. You can view a list of Gregory J. Dore's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Dore's expertise for a condition
ConditionClose
View All 13 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile